Showing 2541-2550 of 4802 results for "".
The Importance of Branding Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/the-importance-of-branding-your-dermatology-practice/20656/Dear Doctor: Here's Why I'm a Long-term Employee
https://practicaldermatology.com/topics/practice-management/dear-doctor-heres-why-im-a-long-term-employee/22068/What makes employees happy and prevents turnover in practice.How To (and How Not To) Build Your Email List
https://practicaldermatology.com/topics/practice-management/how-to-and-how-not-to-build-your-email-list/20636/In an era when we are all inundated with excess email, how can you convince people to subscribe to your newsletter and announcements?Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21764/Pruritus In PN and AD: Challenge How You Manage Itch
https://practicaldermatology.com/programs/cme/pruritus-in-pn-and-ad-challenge-how-you-manage-itch/36304/Use validated assessment tools to prioritize and measure itch in prurigo nodularis and atopic dermatitis in an interactive CME escape room.A Growing Biologics Armamentarium for Psoriasis and Atopic Dermatitis
https://practicaldermatology.com/topics/psoriasis/a-growing-biologics-armamentarium-for-psoriasis-and-atopic-dermatitis/20660/An overview of effective and safe treatment options that continue to come to market to target these chronic conditions.Encouraging Conversation
https://practicaldermatology.com/topics/skin-cancer-photoprotection/encouraging-conversation-40-gep-testing-for-adjuvant-radiation-therapy-candidates/37104/Two studies validate the 40-GEP test for identifying patients most likely to benefit from adjuvant radiation therapyStoking the Embers: Re-exploring Topical Coal Products
https://practicaldermatology.com/columns/clinical-focus-1/stoking-the-embers-re-exploring-topical-coal-products/23825/Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-26/23564/